Virginia Biotechnology Association
VirginiaBio is dedicated to promoting the scientific and economic impact of the biotechnology industry in Virginia. It aims to foster a Virginia life sciences ecosystem recognized for its innovation, success, and contributions to health. The organization supports industry growth through networks, advocacy, capital investment, talent development, and leadership. VirginiaBio also emphasizes education, workforce development, and public policy to strengthen the bioscience sector in Virginia.
Industries
Nr. of Employees
small (1-50)
Virginia Biotechnology Association
800 E. Leigh Street, Richmond, VA 23219-1534
Products
Virginia Bio-Connect (member resource portal)
A web-based portal that lists regional life-science assets, events, jobs and resources to support company discovery and workforce connections.
Virginia Bio-Connect (member resource portal)
A web-based portal that lists regional life-science assets, events, jobs and resources to support company discovery and workforce connections.
Services
Engages with state and federal policymakers, develops policy positions, organizes member advocacy activities and coordinates participation in national advocacy events.
Produces industry conferences, regional forums, pitch competitions and networking sessions to connect companies, investors, academia and policymakers in virtual, hybrid and in-person formats.
Administers programs that place students in experiential internships, funds bioscience camp scholarships, and aligns education and training with employer needs.
Provides member benefits, access to curated resources, and affiliation with an industry purchasing program to secure vendor discounts and reduce organizational costs; reports aggregate member savings.
Operates a cloud-hosted portal to aggregate regional life-science assets, job and event listings, and resource libraries for members and external users.
Curates and publishes industry news, CEO letters and organizational updates; solicits member input and communicates policy, funding and ecosystem developments.
Engages with state and federal policymakers, develops policy positions, organizes member advocacy activities and coordinates participation in national advocacy events.
Produces industry conferences, regional forums, pitch competitions and networking sessions to connect companies, investors, academia and policymakers in virtual, hybrid and in-person formats.
Administers programs that place students in experiential internships, funds bioscience camp scholarships, and aligns education and training with employer needs.
Provides member benefits, access to curated resources, and affiliation with an industry purchasing program to secure vendor discounts and reduce organizational costs; reports aggregate member savings.
Operates a cloud-hosted portal to aggregate regional life-science assets, job and event listings, and resource libraries for members and external users.
Curates and publishes industry news, CEO letters and organizational updates; solicits member input and communicates policy, funding and ecosystem developments.
Expertise Areas
- Policy advocacy and government relations
- Event programming and regional convening (virtual, hybrid, in-person)
- Workforce development and internship placement
- Membership services and negotiated purchasing programs
Key Technologies
- Cloud-based member portals
- Webinar and virtual event platforms
- Event registration and management systems
- Email newsletter and mailing systems
News & Updates
Upcoming event on 7/17/2025 in Richmond, featuring biotech and beer networking.
Annual event on 9/17/2025 focusing on women in bioscience.
Regional biotech forum on 9/23/2025 in Virginia.
Virtual symposium on 5/26-27/2021 about COVID therapeutics.
RIVANNA announced FDA clearance for Accuro 3S and SpineNav-AI™.
CEL-SCI announced the closing of a $5.7 million stock offering.
Upcoming event on 7/17/2025 in Richmond, featuring biotech and beer networking.
Annual event on 9/17/2025 focusing on women in bioscience.
Regional biotech forum on 9/23/2025 in Virginia.
Virtual symposium on 5/26-27/2021 about COVID therapeutics.
RIVANNA announced FDA clearance for Accuro 3S and SpineNav-AI™.
CEL-SCI announced the closing of a $5.7 million stock offering.